1. Home
  2. AEHL vs SCNI Comparison

AEHL vs SCNI Comparison

Compare AEHL & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AEHL

Antelope Enterprise Holdings Limited

HOLD

Current Price

$0.51

Market Cap

2.0M

Sector

Industrials

ML Signal

HOLD

SCNI

Scinai Immunotherapeutics Ltd.

HOLD

Current Price

$0.72

Market Cap

2.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AEHL
SCNI
Founded
1993
2003
Country
China
Israel
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0M
2.3M
IPO Year
2009
2014

Fundamental Metrics

Financial Performance
Metric
AEHL
SCNI
Price
$0.51
$0.72
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
285.1K
7.6M
Earning Date
05-04-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
50.00
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$0.45
52 Week High
$6.53
$6.18

Technical Indicators

Market Signals
Indicator
AEHL
SCNI
Relative Strength Index (RSI) 30.20 55.47
Support Level $0.48 $0.68
Resistance Level $1.46 $1.00
Average True Range (ATR) 0.07 0.10
MACD -0.01 0.02
Stochastic Oscillator 6.92 44.17

Price Performance

Historical Comparison
AEHL
SCNI

About AEHL Antelope Enterprise Holdings Limited

Antelope Enterprise Holdings Ltd operates in three reportable operating segments: Business Management Consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting; Natural Gas Power generation, which was in the initial development stage; and Live-Streaming e-commerce segment, providing a one-stop solution for customers to enable them to utilize the growing sales channel of livestreaming ecommerce. The business of the Company is engaged in the PRC and the United States.

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

Share on Social Networks: